Use of ultrasound pattern recognition by expert operators to identify borderline ovarian tumors: A study of diagnostic performance and interobserver agreement

Ultrasound in Obstetrics and Gynecology

Volumn 35, Issue 1, 2010, Pages 84-88

  Yazbek, J ^a   Ameye, L ^c   Timmerman, D ^d   Testa, A C ^e   Valentin, L ^f   Holland, T K ^a   Van Holsbeke, C ^d   Jurkovic, D ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c Katholieke Universiteit Leuven   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e CATHOLIC UNIVERSITY   (Italy)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Benign; Borderline; Interobserver agreement; Malignant; Ovarian neoplasms; Pattern recognition; Ultrasonography

Indexed keywords

ADNEXAL DISEASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL COMPETENCE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; OVARIAN NEOPLASMS; PATTERN RECOGNITION, VISUAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 74049118004     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.7334     Document Type: Article

References (18)

1. Yazbek J, Raju SK, Ben-Nagi J, Holland TK, Hillaby K, Jurkovic D. Effect of quality of gynaecological ultrasonography on management of patients with suspected ovarian cancer: a randomised controlled trial. Lancet Oncol 2008; 9: 124-131.
2. Valentin L. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol 1999; 14: 273-283.
3. Timmerman D, Schwarzler P, CollinsWP, Claerbout F, Coenen M, Amant F, Vergote I, Bourne TH. Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience. Ultrasound Obstet Gynecol 1999; 13: 11-16.
4. Yazbek J, Raju KS, Ben-Nagi J, Holland T, Hillaby K, Jurkovic D. The accuracy of ultrasound subjective 'pattern recognition' for the diagnosis of borderline ovarian tumors. Ultrasound Obstet Gynecol 2007; 29: 489-495.
5. GotliebWH, Chetrit A,Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, Modan B, Ben-Baruch G; National Israel Ovarian Cancer Study Group. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 2005; 97: 780-783.
6. Boran N, Cil AP, Tulunay G, Ozturkoglu E, Koc S, Bulbul D, Kose MF. Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 2005; 97: 845-851.
7. Ahmed ASM, Lawton FG. Borderline ovarian tumours: Current concepts and management. Rev Gynaecol Pract 2005; 5: 139-151.
8. Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, Copeland L, Silva E, Gorstein F, Young RH. Borderline ovarian tumors: key points and workshop summary. Hum Pathol 2004; 35: 910-917.
9. Education and Practical Standards Committee, European Federation of Societies for Ultrasound in Medicine and Biology. Minimum training recommendations for the practice of medical ultrasound. Ultrashall Med 2006; 27: 79-105.
10. Serov SF, Scully RE, Sobin LH. The World Health Organization International histological classification of ovarian tumours: histological typing of ovarian tumours. World Health Organization: Geneva, 1973.
11. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 1989; 96: 889-892.
12. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992; 304: 1491-1494.
13. Fruscella E, Testa AC, Ferrandina G, De Smet F, Van Holsbeke C, Scambia G, Zannoni GF, Ludovisi M, Achten R, Amant F, Vergote I, Timmerman D. Ultrasound features of different histopathological subtypes of borderline ovarian tumors. Ultrasound Obstet Gynecol 2005; 26: 644-650.
14. Exacoustos C, Romanini ME, Rinaldo D, Amoroso C, Szabolcs B, Zupi E, Arduini D. Preoperative sonographic features of borderline ovarian tumors. Ultrasound Obstet Gynecol 2005; 25: 50-59.
15. Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, GoreME, Kaern J, VerrelstH, Sjövall K, Timmerman D, Vandewalle J, Van Gramberen M, Tropé CG. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001; 357: 176-182.
16. Fauvet R, Boccara J, Dufournet C, Poncelet C, Darai E. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol 2005; 16: 403-410.
17. Cadron I, Leunen K, Van Gorp T, Amant F,Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol 2007; 25: 2928-2937.
18. Ren J, Peng Z, Yang K. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Gynecol Oncol 2008; 110: 162-167.